Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
THC versus hydrocortisone for fear extinction in adults with and without early-life stress
NL-OMON23960Not yet recruiting
- Sponsor
- Radboudumc
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dronabinol and hydrocortisone in post-traumatic stress disorder (PTSD) (2 arms), sponsored by Radboudumc. Primary endpoints: Autonomic nervous system measures during fear memory recall and Subjective US expectancy ratings. Planned start Jan 2018; status: not yet recruiting.
02
Drugs
dronabinolhydrocortisone
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NL-OMON23960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON23960.